Monthly Archive: December 2015

Dec 31

A new study, published in the Journal of Allergy and Clinical Immunology

A new study, published in the Journal of Allergy and Clinical Immunology, finds that having asthma may increase the risk of developing shingles.

Dec 30

Anyone at high risk of a cardiovascular event should be offered blood pressure-lowering drugs

Anyone at high risk of a cardiovascular event should be offered blood pressure-lowering drugs, regardless of their blood pressure at the start of treatment, suggests new research published in The Lancet.

Dec 28

A meta-analysis including more than 600,000 patients in more than 100 studies revealed that antihypertensive therapy significantly decreased the risks of major cardiovascular (CV)

A meta-analysis including more than 600,000 patients in more than 100 studies revealed that antihypertensive therapy significantly decreased the risks of major cardiovascular (CV) events, including stroke and heart failure, and all-cause mortality, almost regardless of baseline BP levels and comorbidities. The findings are published December 23 in the Lancet.

Dec 27

Patients with stable angina taking the heart-rate reducing drug ivabradine had similar self-reported physical limitation scores as patients taking placebo, but better quality of life on other measures

Patients with stable angina taking the heart-rate reducing drug ivabradine had similar self-reported physical limitation scores as patients taking placebo, but better quality of life on other measures, suggested a substudy of the SIGNIFY trial published online in the journal Circulation: Cardiovascular Quality and Outcomes.

Dec 25

Both acute kidney injury and chronic kidney disease were common in patients undergoing major vascular surgical procedures and were associated with an increase in long-term cardiovascular-specific death

Both acute kidney injury and chronic kidney disease were common in patients undergoing major vascular surgical procedures and were associated with an increase in long-term cardiovascular-specific death compared with patients with no kidney disease, reported a study published online in JAMA Surgery.

Dec 25

A meta-analysis, based on data from the Causal Analysis Research in Tobacco and Alcohol (CARTA)

A meta-analysis, based on data from the Causal Analysis Research in Tobacco and Alcohol (CARTA) consortium, published in the December 2015 issue of Circulation: Cardiovascular Genetics, found that part of the cardiovascular risk of smoking may operate through increasing the resting heart rate.

Dec 24

Use of cardiac resynchronization therapy with a defibrillator (CRT-D)

Use of cardiac resynchronization therapy with a defibrillator (CRT-D) significantly lowers risks for adverse clinical outcomes in heart-failure patients with advanced chronic kidney disease (CKD) compared with use of a defibrillator by itself, suggests new research published in the Journal of the American College of Cardiology.

Dec 23

A large, 8-year retrospective study with a median 6.4-year follow-up, published in the American Journal of Cardiology

A large, 8-year retrospective study with a median 6.4-year follow-up, published in the American Journal of Cardiology, linked long–term statin use with an increased risk of kidney disease. Statin users, compared with case-matched controls who didn’t use statins, showed a 30% to 36% greater prevalence of kidney disease during follow–up.

Dec 16

Spending large amounts of time participating in sedentary behaviors

Spending large amounts of time participating in sedentary behaviors, such as watching TV and checking the computer, by patients with CAD can worsen various cardiometabolic markers—even if the patients also spend time exercising, suggests a secondary analysis of the Efficacy and Economics of Exercise Maintenance Post-Cardiac Rehabilitation (ECO-PCR) study, published online in the European Journal …

Continue reading »

Dec 14

Patients with atrial fibrillation (AF) who received a left atrial appendage closure device (Watchman)

Patients with atrial fibrillation (AF) who received a left atrial appendage closure device (Watchman) or stayed on long–term warfarin therapy had similar rates of major bleeding during a mean follow–up of 3.1 years, suggested a pooled analysis of two randomized clinical trials published online in JACC: Cardiovascular Interventions. However, patients who received the device and …

Continue reading »

Older posts «